Verastem Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:2VSA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
05 May 25	Sell€5,284	Daniel Paterson	Individual	820	€6.44
24 Mar 25	Sell€584	Daniel Calkins	Individual	91	€6.52
17 Mar 25	Sell€3,774	Brian Stuglik	Individual	593	€6.36
17 Mar 25	Sell€1,553	Daniel Paterson	Individual	244	€6.36
17 Mar 25	Sell€1,808	Robert Gagnon	Individual	284	€6.36
04 Feb 25	Sell€4,714	Daniel Paterson	Individual	858	€5.49
13 Jan 25	Sell€44,016	Daniel Paterson	Individual	8,568	€5.14
06 Jan 25	Sell€40	Daniel Calkins	Individual	6	€6.68
24 Dec 24	Sell€377	Daniel Calkins	Individual	93	€4.18
19 Dec 24	Sell€4,008	Brian Stuglik	Individual	929	€4.37
19 Dec 24	Sell€1,837	Daniel Paterson	Individual	427	€4.37
19 Dec 24	Sell€1,793	Robert Gagnon	Individual	415	€4.37
05 Nov 24	Sell€2,856	Daniel Paterson	Individual	812	€3.52
07 Oct 24	Sell€16	Daniel Calkins	Individual	6	€2.61
24 Sep 24	Sell€231	Daniel Calkins	Individual	93	€2.51
19 Sep 24	Sell€842	Brian Stuglik	Individual	336	€2.50
19 Sep 24	Sell€328	Robert Gagnon	Individual	131	€2.50
19 Sep 24	Sell€461	Daniel Paterson	Individual	184	€2.50
16 Sep 24	Sell€1,510	Brian Stuglik	Individual	600	€2.52
16 Sep 24	Sell€619	Daniel Paterson	Individual	246	€2.52
16 Sep 24	Sell€722	Robert Gagnon	Individual	287	€2.52
05 Aug 24	Sell€6,388	Daniel Paterson	Individual	3,245	€1.97
09 Jul 24	Sell€17	Daniel Calkins	Individual	7	€2.42
24 Jun 24	Sell€82	Daniel Calkins	Individual	28	€2.94
20 Jun 24	Sell€2,935	Brian Stuglik	Individual	928	€3.26
20 Jun 24	Sell€198	Daniel Calkins	Individual	67	€2.95
20 Jun 24	Sell€1,343	Daniel Paterson	Individual	427	€3.26
20 Jun 24	Sell€1,314	Robert Gagnon	Individual	414	€3.26

Insider Trading Volume

Insider Buying: 2VSA insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2VSA?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	232,043	0.422%
VC/PE Firms	2,862,448	5.21%
General Public	9,008,600	16.4%
Hedge Funds	9,033,451	16.4%
Institutions	33,812,628	61.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 117%.

Top Shareholders

Top 25 shareholders own 76.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.71%	Balyasny Asset Management L.P.	4,787,975	€32.9m	21.3%	0.09%
7.73%	RTW Investments, LP	4,245,476	€29.2m	0%	0.49%
5.21%	OrbiMed Advisors LLC	2,862,448	€19.7m	0%	0.35%
4.95%	AIGH Investment Partners, L.L.C.	2,717,827	€18.7m	0%	no data
4.81%	Rosalind Advisors, Inc.	2,644,517	€18.2m	194%	6.88%
4.61%	BlackRock, Inc.	2,534,008	€17.4m	3.79%	no data
4.42%	The Vanguard Group, Inc.	2,430,110	€16.7m	5.13%	no data
4.25%	Aigh Capital Management, LLC	2,337,754	€16.1m	-12.3%	8.13%
4.18%	Nantahala Capital Management, LLC	2,298,541	€15.8m	-38.8%	1.25%
4.05%	Marshall Wace LLP	2,225,594	€15.3m	180%	0.02%
3.82%	BVF Partners L.P.	2,100,468	€14.4m	0%	0.62%
3.13%	Octagon Capital Advisors LP	1,720,000	€11.8m	0%	2.59%
2.8%	Vivo Capital, LLC	1,538,461	€10.6m	0%	0.97%
2.04%	Morgan Stanley, Investment Banking and Brokerage Investments	1,122,634	€7.7m	44%	no data
1.75%	Geode Capital Management, LLC	960,264	€6.6m	1.21%	no data
1.7%	Soleus Capital Management, L.P.	935,909	€6.4m	-57.2%	0.51%
1.48%	State Street Global Advisors, Inc.	812,150	€5.6m	9.5%	no data
1.13%	Goldman Sachs Group, Investment Banking and Securities Investments	620,123	€4.3m	453%	no data
1.12%	Stonepine Capital Management LLC	613,000	€4.2m	-29.5%	2.26%
1.09%	Casdin Capital, LLC	600,000	€4.1m	0%	0.39%
0.95%	UBS O'Connor LLC	521,960	€3.6m	-14.2%	0.53%
0.91%	Integral Health Asset Management, LLC	500,000	€3.4m	0%	0.42%
0.82%	Acorn Bioventures	452,110	€3.1m	-42%	2.42%
0.62%	Northern Trust Global Investments	338,700	€2.3m	-0.17%	no data
0.61%	Superstring Capital Management LP	336,363	€2.3m	60.3%	3.18%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/20 14:38
End of Day Share Price	2025/05/20 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Verastem, Inc. is covered by 24 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Matthew Cross	Alliance Global Partners
James Molloy	Alliance Global Partners
Kalpit Patel	B. Riley Securities, Inc.